Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Optase
Generic name
GLYCERIN
Manufacturer
Scope Health Inc
Product type
HUMAN OTC DRUG
SPL set ID
376e0289-28e9-e87f-e063-6294a90a3b04
SPL ID
5eb2047f-2147-3915-e063-6294a90aca6b
Version
5
Effective date
2026-10-25
Source export date
2026-11-13
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/0ccebc9befe0ec22afe916211b2687f6eef8ed163963720f103786a7f2d2e3ae/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:32:19
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning ■ For external use only. ■ If solution changes color or becomes cloudy, do not use. ■ To avoid contamination, do not touch tip of container to any surface. Replace cap after using. Stop use and ask doctor if ■ You feel eye pain. ■ Changes in vision occur. ■ Redness or irritation of the eye lasts. ■ Condition worsens or lasts more than 72 hours.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.